Although CFTR is expressed in the kidney, no overwhelming renal phenotype has been documented in patients with CF. This study investigated the expression, subcellular distribution, and processing of CFTR in the kidney; used various mouse models to assess the role of CFTR in proximal tubule (PT) endocytosis; and tested the relevance of these findings in patients with CF. The level of CFTR mRNA in mouse kidney approached that found in lung. CFTR was located in the apical area of PT cells, with a maximal intensity in the straight part (S3) of the PT. Fractionation showed that CFTR co-distributed with the chloride/proton exchanger ClC-5 in PT endosomes. Cftr ؊/؊ mice showed impaired 125 I-␤ 2 -microglobulin uptake, together with a decreased amount of the multiligand receptor cubilin in the S3 segment and a significant loss of cubilin and its low molecular weight (LMW) ligands into the urine. Defective receptor-mediated endocytosis was found less consistently in Cftr ⌬F/⌬F mice, characterized by a large phenotypic heterogeneity and moderate versus mice that lacked ClC-5. A significant LMW proteinuria (and particularly transferrinuria) also was documented in a cohort of patients with CF but not in patients with asthma and chronic lung inflammation. In conclusion, CFTR inactivation leads to a moderate defect in receptor-mediated PT endocytosis, associated with a cubilin defect and a significant LMW proteinuria in mouse and human. The magnitude of the endocytosis defect that is caused by CFTR versus ClC-5 loss likely reflects functional heterogeneity along the PT.
C ystic fibrosis (CF; MIM #219700), the most common autosomal recessive disease in white individuals, is caused by mutations in the CFTR gene that encodes the chloride channel cystic fibrosis transmembrane conductance regulator (CFTR) (1, 2) . CFTR is a 1480 -amino acid protein that belongs to the ATP-binding cassette (ABC) family of integral membrane proteins. It is located mainly in the apical membrane area of secretory epithelia, where it functions as a cAMP-dependent chloride channel and as a conductance regulator via interactions with other ion channels (2) . Mutations in CFTR are classified into five groups according to their structural or functional consequences on the protein. The deletion of three bases that encode a phenylalanine residue at position 508 (⌬F508), which occurs in approximately 70% of patients with CF, results in the misfolding and lack of maturation of the CFTR protein (3) . Most of the clinical features that are observed in patients with CF and CF mouse models originate from mucosal obstruction of exocrine glands, such as the respiratory system, pancreas, intestine, gallbladder, and sweat glands (1) (2) (3) .
Besides exocrine epithelia, CFTR has been located in the mammalian kidney, which primarily ensures reabsorptive functions (4) . During human nephrogenesis, CFTR is expressed in the apical membrane of the branching ureteric bud and, later, in the apical pole of proximal tubule (PT) cells in the cortex, where it remains detected after birth (5, 6) . A functional truncated isoform also has been described in the kidney, with a distinct ontogeny pattern and a minor plasma membrane expression (7, 8) . Despite the high level of CFTR expression in the developing and mature kidney, no overwhelming renal phenotype has been associated with CF (4, 9) . Instead, a spectrum of renal diseases is apparent from the neonatal period to later in life. Microscopic nephrocalcinosis has been reported in an autopsy series of patients who had CF and ranged in age from birth to 36 yr (10) , and the incidence of kidney stones in patients with CF also may be increased (11) . However, the relative contribution of lithogenic factors, such as hypocitraturia, or impaired hydration remains elusive. A decreased capacity to dilute urine, together with reduced urinary sodium excretion, also has been reported in patients with CF (12) . This could result from a primary defect in kidney function or simply reflect changes in the extracellular fluid volume that is caused by excessive losses of NaCl in sweat and feces. In addition, patients with CF show an enhanced renal clearance of many drugs, including aminoglycosides (13) , and subtle abnormalities in kidney development, function, and/or morphology may appear in later stages of CF (6) .
In addition to its location in the apical membrane, CFTR is distributed in intracellular organelles along the endocytic and secretory pathways (14, 15) . Inhibition of endocytic activity, as well as defective acidification in trans-Golgi and prelysosomal compartments, has been reported in CF cells (16) . However, the exact role of CFTR in regulating organelle pH remains controversial, with hyper-rather than hypo-acidification suggested to occur in CF respiratory epithelial cells (17) . Recent findings about the endosomal protein ClC-5, which belongs to the CLC family of Cl Ϫ channels/exchangers, have provided insights into the role of anion transporters in PT cells (18) . In normal conditions, low molecular weight (LMW) proteins as well as albumin and transferrin in some species are ultrafiltered by the glomerular membrane but almost entirely reabsorbed by receptor-mediated endocytosis at the apical side of PT cells (19) . The loss of ClC-5, which co-distributes with the vacuolar H ϩ -ATPase (V-ATPase) in PT endosomes, causes a major defect in receptor-mediated endocytosis and an LMW proteinuria in Clcn5 knockout (KO) mice (20, 21) as in patients with Dent's disease, which is caused by inactivating mutations in CLCN5 (22) . By analogy, other intracellular anionic transporters such as CFTR might play a role in the endocytic reabsorption of LMW proteins by the kidney (4, 18) . In this study, we describe the segmental and subcellular distribution of CFTR in the kidney, at both the mRNA and protein levels. Taking advantage of Cftr Ϫ/Ϫ and Cftr ⌬F/⌬F mutant mice, we characterize the role of CFTR in PT apical endocytosis, in comparison with the Clcn5 Y/Ϫ mouse model. Finally, we evaluate the renal handling of LMW proteins in cohorts of patients who have CF and harbor the ⌬F508 mutation and patients with chronic lung inflammation as a result of asthma, each compared with age-and gender-matched control subjects. 
Materials and Methods

CF Mouse Models
Microdissection Studies
Kidneys from male C57BL/6 mice were dissected and minced before incubation with 0.1% (wt/vol) type 2 collagenase solution that contained 100 g/ml soybean trypsin inhibitor for 30 min at 37°C. After digestion, the supernatant was sieved through 250-and 80-m nylon filters. Nephron fragments remained in the 80-m sieve and were resuspended by flushing. Distinct segments (glomeruli, S1 and S3 PT, thick ascending limbs [TAL] , and inner medullary collecting ducts [IMCD]) were isolated upon their morphologic features (26) and preserved in RNA later (Westburgh, Leusden, The Netherlands). Four distinct collections were snap-frozen in liquid nitrogen and conserved at Ϫ80°C. The extraction of total RNA was performed using RNAqueous-Micro (Ambion, Huntingdon, UK).
Real-Time Reverse Transcriptase-PCR Analyses
Total RNA from mouse kidney samples was extracted by Trizol (Invitrogen, Merelbeke, Belgium), treated with DNase I (Invitrogen), and reverse-transcribed into cDNA using SuperScript II Rnase H (Invitrogen). Specific mouse primers were designed using Beacon Designer 2.0 (Premier Biosoft International, Palo Alto, CA; see Supplementary Table 1 ). Real-time reverse transcriptase-PCR (RT-PCR) analyses were performed in duplicate with 200 nM of both sense and antisense primers in a final volume of 25 l of iQ SYBR Green Supermix (Bio-Rad, Nazareth, Belgium). The PCR mixture contained 10 nM fluorescein for initial well-to-well fluorescence normalization. PCR conditions were settled as incubation at 94°C for 3 min followed by 40 cycles of 30 s at 95°C, 30 s at 61°C, and 1 min at 72°C. The melting temperature of PCR product was checked at the end of each PCR by recording SYBR green fluorescence increase upon slowly renaturing DNA. For each assay, standard curves were prepared by serial four-fold dilutions of mouse adult kidney cDNA, and primer efficiencies were calculated [efficiency ϭ (10 Table 1 ). CFTR mRNA expression was investigated in four adult male lungs and kidneys, after normalization to HPRT1: Ratio ϭ 2
. CFTR mRNA expression was quantified further in S1 versus S3 PT samples:
. Real-time PCR results were confirmed with two sets of primers for CFTR and ClC-5 and using two reporter genes, HPRT1 and GAPDH.
Antibodies
The following antibodies were used: Affinity-purified rabbit polyclonal antibodies (MD1314) against the C-terminus of rodent CFTR (27) 
Western Blotting and Deglycosylation Studies
Membrane extracts were prepared as described previously (28) . Kidney samples were homogenized in ice-cold sucrose buffer that contained Complete protease inhibitors (Roche, Vilvoorde, Belgium) and centrifuged at 1000 ϫ g for 15 min at 4°C. The supernatant was centrifuged at 100,000 ϫ g for 120 min at 4°C. The resulting pellet ("membrane" fraction) was suspended in ice-cold homogenization buffer and stored at Ϫ80°C. Protein concentrations were determined with the bicinchoninic acid protein assay using BSA as standard. Deglycosylation studies using N-glycosidase F and endoglycosidase H (Roche) were performed following the manufacturer's recommendations. Equal loading was verified by reprobing against ␤-actin. All immunoblots were performed at least in duplicate.
Immunostaining
Kidney samples were fixed in 4% formaldehyde (Boehringer Ingelheim, Heidelberg, Germany) in 0.1 M phosphate buffer (pH 7.4), before embedding in paraffin as described (28) . Six-micrometer sections first were incubated in 0.01 M citrate buffer (pH 5.8) for 75 min in a water bath heated at 97°C before cooling and rinsing. After endogenous peroxidase was blocked for 30 min with 0.3% hydrogen peroxide, sections were incubated with 10% normal serum, then with the primary antibodies diluted in PBS that contained 2% BSA. After washing, sections were incubated successively with biotinylated secondary anti-IgG antibodies, avidin-biotin peroxidase, and aminoethylcarbazole (Vector Laboratories, Brussels, Belgium). For immunohistofluorescence, freshly collected kidneys were immersed in Tissue-Tek OCT compound (Sakura Finetek, Zoeterwoude, The Netherlands) and frozen at Ϫ80°C. Tissue sections (5 m thick) were dried overnight at 37°C, fixed with ice-cold formaldehyde 4% for 10 min, washed with PBS, and processed for immunostaining. Secondary antibodies were goat anti-rabbit and donkey anti-sheep coupled to Alexa 488 (Molecular Probes, Merelbeke, Belgium). Sections were viewed under a Leica DMR coupled to a Leica DC300 digital camera (Leica, Heerbrugg, Switzerland).
Analytical Subcellular Fractionation
Kidneys were homogenized in 0.25 M sucrose and 3 mM imidazole buffer (pH 7.4) that contained Complete (Roche), in a Potter-Elvehjem tissue homogenizer (Thomas Scientific, Swedesboro, NJ) (29) . A lowspeed "nuclear" fraction was pelleted at 700 ϫ g for 10 min and extracted twice by resuspension/sedimentation; pooled postnuclear supernatants were sedimented further at 100,000 ϫ g for 60 min in a 50Ti fixed-angle rotor (Beckman, Palo Alto, CA). This high-speed pellet was resuspended in 1 ml of homogenization buffer, mixed with 7 ml of 16% (vol/vol) Percoll (average final density 1.048 g/ml), layered over a 250-l Percoll cushion, and centrifuged at 60,000 ϫ g for 30 min in a 50Ti rotor into a self-generating gradient. Ten fractions (750 l each) were collected from the bottom and numbered from 1 (light) to 10 (dense).
Measurement of Endocytic Tracer Uptake
Mice were anesthetized under anesketin (Eurovet, Brussels, Belgium) and rompun (Bayer, Brussels, Belgium) and injected intravenously with 620 ng/g body wt radiolabeled 125 I-␤ 2 -microglobulin (Sigma). After 7 min, kidneys were exsanguinated in situ. One kidney was fixed for 6 h at 4°C in 4% formaldehyde for further investigations, such as immunostaining and autoradiography. The contralateral kidney and the liver were homogenized and analyzed biochemically as previously reported (25) .
Urine and Plasma Analyses
Mice were kept in metabolic cages for 24 h with ad libitum access to food and drinking water. Urine was collected on ice-cold Complete (Roche). Blood was obtained by aorta puncture at the time of killing. Plasma and urine levels of electrolytes, urea, and creatinine were measured by standard methods (Eastman Kodak Co., Rochester, NY), whereas CC16 concentration, a 16-kD marker for PT dysfunction, was determined in duplicate by latex immunoassay (21) . Acid-base parameters in mouse urine and blood were determined using ABL 77 series apparatus (Radiometer, Copenhagen, Denmark).
Cohorts of Patients and Control Subjects
Two cohorts of patients were sampled for urinalyses. The first cohort included 30 patients with CF (range 3 to 39 yr of age) with their ageand gender-matched healthy control subjects. The diagnosis of CF was based on clinical characteristics and a positive sweat testing (3). Genotyping identified the ⌬F508 mutation in all patients (homozygous in 25 of 30; heterozygous with N1303K, G542X, or 3849 10 kb C⌸T in three of 30; second mutation not identified in two of 30). The second cohort included 25 patients with chronic active asthma (range 3 to 49 yr of age) and age-and gender-matched healthy control subjects. First-morning (CF cohort) or second-morning (asthma cohort) urine samples were analyzed for creatinine, albumin, CC16, ␤ 2 -microglobulin, transferrin (30, 31) , and calcium. Both cohorts were sampled during their routine follow-up at the St.-Luc Academic Hospital (Brussels, Belgium). The protocol was approved by the Université catholique de Louvain Ethical Review Board. All patients and control subjects gave informed consent.
Statistical Analyses
Unless specified otherwise, data are means Ϯ SEM. Non-normally distributed parameters were compared after log transformation. Univariate analysis was performed using Pearson cross-product correlations. A multiple stepwise linear regression model was performed to assess the significant determinants of the urine protein ratios (age, gender, disease state, and previous aminoside treatment). All analyses were performed using SPSS V11.5.1 software (Chicago, IL).
Results
Expression and Distribution of CFTR mRNA and Protein in Mouse Kidney
Real-time RT-PCR analyses showed that the level of CFTR mRNA in adult mouse kidney reached approximately 60% of that found in lung, considered as reference organ ( Figure 1A ). The segmental distribution of CFTR mRNA in mouse nephron was investigated using tubular fractions that were obtained by microdissection. These fractions were characterized for segment-specific markers, such as podocin (glomeruli), AQP1 (PT), ClC-Kb (TAL), and AQP2 (IMCD; Figure 1B ). The tissue-nonspecific alkaline phosphatase (tnAP) was approximately eightfold enriched in samples from the convoluted (S1 to S2) part of the PT, allowing them to be distinguish from the straight descending (S3) PT segment ( Figure 1C ) (32) . In these tubular fractions, CFTR mRNA was approximately three-fold more expressed in the straight S3 than in S1 to S2 PT fragments, in contrast with stable ClC-5 mRNA abundance ( Figure 1C ). Note that RT-PCR using three different sets of primers did not detect CFTR in glomeruli, TAL, and IMCD.
Immunoblotting demonstrated a distinct pattern for CFTR in mouse kidney and lung ( Figure 1D ). In lung samples, both the partially glycosylated precursor (B band at approximately 150 kD) and the fully glycosylated (C band at approximately 180 kD) CFTR were distinguished clearly. In the kidney, CFTR was detected as a single, approximately 160-kD band. Deglycosylation studies demonstrated that the core CFTR was detected at approximately 150 kD in both tissues, suggesting that the Nglycosylation pattern of CFTR may be tissue specific (Figure ) is approximately eight-fold greater in S1 than in S3 PT segments. ClC-5 mRNA is equivalent in S1 and S3 samples, whereas CFTR expression is approximately three-fold more abundant in S3 than in S1 segments (n ϭ 4). (D) Representative immunoblotting for CFTR in lung and kidney from Cftr ϩ/ϩ and Cftr Ϫ/Ϫ mice. Membrane extracts (30 g/lane) were run on 5% PAGE and transferred to nitrocellulose. The blot was probed with MD1314 anti-CFTR antibodies (1:500) and, after stripping, ␤-actin (1:10,000). In lung, both B (150 kD) and C bands (180 kD) are present, whereas, in kidney, CFTR is detected as a single large band at approximately 160 kD (asterisk at right). In both tissues, immunoreactive bands for CFTR are absent in Cftr Ϫ/Ϫ extracts. (E) Differential glycosylation of CFTR in mouse lung and kidney. Samples were incubated with (ϩ) or without (Ϫ) N-glycosidase F for 90 min at 37°C. Treatment with N-glycosidase F induces a shift of CFTR bands to a lower molecular weight, indicating the presence of Asn-linked glycan chains in both lung and kidney samples, with CFTR core protein at approximately 150 kD. (F) Representative immunoblotting for ⌬F508-CFTR in lung and kidney. In Cftr ⌬F/⌬F lung, the fully glycosylated protein (C band) strongly decreases, whereas the B band increases. In the Cftr ⌬F/⌬F kidney, there is a strong reduction in the CFTR immunodetection signal at 160 kD (*), requiring longer film exposure (60 min versus 1 min) for visualization. 1E). In contrast to various antibodies, the MD1314 antibodies used here did not detect any immunoreactive bands in tissue extracts from Cftr Ϫ/Ϫ mice ( Figure 1D ). The ⌬F508 mutation is known to alter CFTR processing in lung (2) . As shown in Figure  1F , the fully glycosylated C band was reduced markedly in Cftr ⌬F/⌬F lung samples, whereas the B band was increased. In Cftr ⌬F/⌬F kidney, a residual expression of ⌬F508-CFTR was detected as a faint specific band at approximately 160 kD. These results validate the specificity of anti-CFTR antibodies that were used in this study and suggest a tissue-specific processing of CFTR. They also show that the defect of CFTR biosynthesis and/or stability that is caused by the ⌬F508 mutation, previously documented in lung, also occurs in the kidney.
Segmental Localization and Subcellular Distribution of CFTR
Immunostaining that was performed on mouse kidney showed that CFTR is strongly detected at the corticomedullary junction, whereas the distribution of the PT multiligand receptor megalin includes both inner and outer cortices, as well as the outer stripe of the outer medulla ( Figure 2, A and B) . The co-localization of CFTR with AQP1 indicated that CFTR was detected in the apical area of PT cells. The signal was faint in S1 to S2 segments and stronger in the S3 segment of PT, close to the transition to the descending thin limb of Henle's loop (Figure 2, C, D, F, and G) . The segmental location of the ⌬F508-CFTR was similar to that of normal CFTR, including the apical region of the distal part of PT, although the immunoreactive signal was weaker than in control kidneys ( Figure 2E ). No specific signal for CFTR was detected in Cftr Ϫ/Ϫ kidneys (Figure 2H) . The subcellular distribution of CFTR in the kidney was investigated further by fractionation in Percoll gradients ( Figure  3 ). These gradients resolved a low-density peak (fractions 2 through 5), including the early endosomal marker Rab5a; an intermediate density peak (fractions 7 through 9), including the brush border marker villin; and a bottom peak enriched in lysosomes (cathepsin D marker). The bulk of CFTR was detected in the endosomal fractions 3 through 4, where it colocalized with the vacuolar proton pump V-ATPase (E1 subunit) and ClC-5.
Altogether, these data support that, in mouse kidney, CFTR is particularly abundant in the S3 PT cells, with a subcellular distribution similar to ClC-5 and the V-ATPase in endosomes. Despite a weaker expression, the segmental location of the ⌬F508-CFTR was preserved in mouse kidney.
Evaluation and Characterization of PT Apical Endocytosis in CF Mouse Models
Having established the segmental distribution of CFTR in the kidney, we investigated whether its disruption (Cftr Ϫ/Ϫ mice) or altered processing (Cftr ⌬F/⌬F mice) influenced renal and PT function in mouse. Plasma and urine analyses revealed that the renal function was normal in both Cftr Ϫ/Ϫ and Cftr ⌬F/⌬F mice (Table 1) , with similar plasma bicarbonate and urine pH levels (data not shown). However, the significant increase in the urinary excretion of the LMW Clara cell protein (CC16, 16 kD) in Cftr Ϫ/Ϫ mice versus controls, contrasting with similar plasma levels, suggested a deficient PT handling of LMW proteins in Cftr Ϫ/Ϫ mice. To test that hypothesis, we injected CF and control mice intravenously with 125 I-␤ 2 -microglobulin, a LMW protein that is filtered freely by the glomerulus and taken up by receptor-mediated endocytosis in PT cells (25) . After 7 min, renal uptake of 125 I-␤ 2 -microglobulin was decreased significantly (up to 50%) in Cftr Ϫ/Ϫ mice versus their matched controls ( Figure 4A ). Liver uptake of 125 I-␤ 2 -microglobulin, which was ⌬F/⌬F (E), and Cftr Ϫ/Ϫ (H) kidneys. In control kidney, CFTR is detected preferentially at the corticomedullary junction, whereas megalin encompasses both inner and outer cortices and the outer stripe of the outer medulla (OSOM; compare A and B). The segmental co-localization of CFTR and AQP1 (C, D, F, and G) indicates that CFTR is particularly abundant in the apical area of the distal S3 segment of PT, just before the transition with the descending thin limb (F and G, arrowheads). No specific staining is observed in Cftr Ϫ/Ϫ kidney (H), whereas ⌬F508-CFTR is detected with a lower intensity (requiring longer chromogenic reaction) in the S3 segment of PT (E). Bars ϭ 500 m in A and B; 100 m in F and G); 50 m in C, D, E, and H). g, glomerulus.
used as internal control because CFTR is not expressed in hepatocytes, was similar in both groups (data not shown). The Cftr ⌬F/⌬F population showed an approximately 30% decrease of 125 I-␤ 2 -microglobulin uptake, the phenotype heterogeneity probably reflecting the variable, residual expression of ⌬F508-CFTR in kidney ( Figure 4B ). Densitometry analyses estimated a 10-fold decrease (ranging from 5 to 20% of Cftr ϩ/ϩ level) of CFTR abundance in Cftr ⌬F/⌬F kidneys in comparison with controls. The renal phenotype of Cftr Ϫ/Ϫ mice was mild in comparison with Clcn5 Y/Ϫ mice, characterized by a major defect (approximately 85%) in 125 I-␤ 2 -microglobulin renal uptake (Figure 4A) .
To assess the role of CFTR in the segmental reabsorption of LMW proteins in the PT, we correlated the distribution of CFTR (immunostaining) and 125 I-␤ 2 -microglobulin (autoradiography) on adjacent serial sections ( Figure 4C ). These studies showed that 125 I-␤ 2 -microglobulin uptake occurred mostly in S1 to S2 PT segments that expressed megalin and ClC-5, whereas only a residual reabsorption was observed in the S3 PT segments with high CFTR immunoreactivity ( Figure 4C, arrowheads) . We next evaluated the total content of endocytic actors (megalin, cubilin, and ClC-5) in CF versus control kidneys ( Figure 5 ). No significant changes were observed in the kidneys from Cftr ⌬F/⌬F mice (data not shown). In contrast, a specific decrease of cubilin expression was observed in Cftr Ϫ/Ϫ kidneys ( Figure   5A ), although no deficit was found at the mRNA level (data not shown). Immunofluorescence staining showed that the intensity of cubilin staining in Cftr Ϫ/Ϫ PT cells was markedly weaker at the corticomedullary junction (S3 PT segment) than in the outer cortex, whereas no differences were observed in Cftr ϩ/ϩ kidneys ( Figure 5B ). The differential immunoreactive pattern of cubilin in the Cftr Ϫ/Ϫ S3 PT cells was specific, because no similar modifications were observed for megalin ( Figure 5B ). Such cubilin defect was reflected further by the urinary loss of its ligand transferrin (76 kD) in the Cftr Ϫ/Ϫ mice ( Figure 5C ). To investigate further the biosynthesis and processing of cubilin, we performed deglycosylation assays in Cftr Ϫ/Ϫ versus Cftr ϩ/ϩ kidney samples, showing that cubilin correctly matured into its endoglycosidase H-resistant, N-glycosidase F-sensitive form in both groups ( Figure 6A ). In contrast, the abundance of cubilin in Cftr Ϫ/Ϫ mouse urine was increased significantly in comparison with controls, with no change of megalin urinary excretion levels ( Figure 6B ). These data suggest that in Cftr Ϫ/Ϫ mice, the complete loss of CFTR induces a significant decrease in the membrane stability and increased urinary excretion of cubilin, leading to a defective apical receptor-mediated endocytosis in PT cells, with urinary loss of LMW ligands (␤ 2 -microglobulin, CC16, and transferrin). This phenotype is observed less consistently in Cftr ⌬F/⌬F mice, which may be explained by a variable residual expression and/or functionality of the mutated ⌬F508-CFTR in the Cftr ⌬F/⌬F kidneys (24, 33) .
Evaluation of PT Endocytosis in Patients with CF or Chronic Lung Inflammation
To substantiate the renal phenotype that was found in CF mouse models, we analyzed the urinary excretion of LMW proteins in a first series of stable patients with CF versus age-and gender-matched control subjects (n ϭ 30 pairs). A second series of patients with chronic active asthma and their appropriate control subjects (n ϭ 25 pairs) were investigated to rule out the potential interference of chronic lung inflammation with renal PT function. Figure 7 shows that, when normalized to the appropriate controls, there was a major, 30-fold increase in the transferrinuria, as well as a significant, two-fold increase in the urinary excretion of albumin, CC16, and ␤ 2 -microglobulin in patients with CF, whereas there were no significant changes in patients with asthma (Supplementary Table 2 ). No changes in the urinary concentration of calcium were observed. A multivariate model using stepwise regression showed that the four urinary protein ratios were associated significantly with CF, independent of gender, age, and previous treatment with aminosides, whereas no significant association existed with asthma. These data support that the PT dysfunction that was observed in the CF cohort likely is caused by CFTR dysfunction itself rather than a chronic state of lung inflammation.
Discussion
The spectrum of CF, which previously was considered as a respiratory and digestive disease associated with a rapidly fatal outcome, has broadened considerably in the past decade. The disease includes many milder cases, which are associated with a longer survival and a potential for developing complications in multiple organs (2,3) . On the basis of recent insights into the , respectively, were run on 5% PAGE and transferred to nitrocellulose. The blots were probed with MD1314 anti-CFTR antibodies (1:500) and ␤-actin (1:10,000), respectively. Densitometry showed that residual expression of ⌬F508-CFTR averages 10-fold, with high individual variability between Cftr ⌬F/⌬F kidney samples. (C) Comparative localization of CFTR and endocytosed 125 I-␤ 2 -microglobulin (7 min) in mouse kidney. CFTR immunodetection and autoradiography were performed on serial kidney sections. CFTR is expressed preferentially in the inner cortex, whereas endocytosed 125 I-␤ 2 -microglobulin is detected in both inner and outer cortices. The CFTR-positive tubules that are positive for 125 I-␤ 2 -microglobulin (insets, arrowhead) provide a molecular explanation for the defect in receptor-mediated endocytosis. Bars ϭ 500 m; 100 m (inset).
Rab5a and the V-ATPase in PT cells. The striking contrast between the severe PT dysfunction that is associated with ClC-5 loss and the mild renal phenotype of CF probably reflects the distribution of these transporters in specialized segments of the PT.
Although the role of CFTR in exocrine epithelia, including trachea and small intestine, has been studied extensively (2, 3) , the issues of CFTR distribution, processing, and function in the kidney remain debated (4 -9). In rat kidney, immunostaining for CFTR was shown at the apical surface of both proximal and distal tubules but was not detected in the outer medullary CD (5). In the human kidney, CFTR protein expression was found in the PT, thin limbs of Henle's loop, distal tubules, and collecting ducts (5-7). Our studies in mouse kidney (using antibodies of strict specificity) show that CFTR is expressed in the apical area of PT cells, with a maximal intensity in the S3 part of the PT. Furthermore, the electrophoretic mobility of N-glycosylated CFTR is slightly different in kidney versus lung, although CFTR core protein is detected at approximately 150 kD in both tissues. The established relationship between CFTR glycosylation and its stability/function at the plasma membrane (34) suggests that the distinct CFTR maturation in the kidney may reflect distinct trafficking/targeting and possibly different channel activity within tubular cells (35) .
In parallel to its role in regulating chloride permeability across the apical membrane, CFTR also may facilitate the acidification of intracellular organelles along the endocytic pathway (15) . Accordingly, an acidification defect was found in transGolgi and prelysosomal compartments in immortalized respiratory epithelial cells and nasal polyps from patients with CF (16) . More recently, however, enhanced rather than decreased acidification was reported in endosomes of CF respiratory epithelial cells (17) . Our fractionation data show that, in mouse kidney, CFTR co-distributes with ClC-5 and the V-ATPase in PT (C through F) kidneys. Cubilin is detected in all PT segments of the outer cortex (A and C) and the corticomedullary junction of Cftr ϩ/ϩ and Cftr Ϫ/Ϫ kidneys. In Cftr Ϫ/Ϫ kidneys, the immunoreactive signal of cubilin in S3 PT (D) is weaker (insets) than in S1 through S2 segments (C), without changes in megalin abundance (E and F). Immunostaining experiments were performed strictly in parallel on two distinct Cftr ϩ/ϩ and Cftr Ϫ/Ϫ paired samples. Green fluorescence was visualized during 3 ms using the software IM50 (Zeiss, Zaventem, Belgium) through a Zeiss Axiovert S100 microscope equipped with an Axiocam camera. Bars ϭ 50 m; 20 m (insets). (C) Urinary excretion of transferrin in Cftr ϩ/ϩ and Cftr Ϫ/Ϫ mice. Urine samples were loaded on 7.5% PAGE, blotted to nitrocellulose, and incubated with rabbit antibody anti-transferrin (1:1000). Loading volume was normalized to urine creatinine concentration; urine from Clcn5 Y/Ϫ mouse was used as positive control (21) . Transferrin, a specific ligand of cubilin, is detected in the urine from Cftr Ϫ/Ϫ mice but absent in the Cftr ϩ/ϩ samples.
endosomes, pointing to a possible involvement in apical endocytosis. The endocytic uptake of LMW proteins is mediated by the multiligand receptors megalin and cubilin, which are particularly expressed at the apical surface of cells that line the S1 to S2 segments of the PT (19) . Recently, the vesicular chloride/proton exchanger ClC-5 has been involved clearly in renal endocytosis (20 -22) . Mutations of CLCN5 gene that encodes ClC-5 cause Dent's disease, a tubulopathy that essentially is characterized by a generalized dysfunction of the PT associated with LMW proteinuria, hypercalciuria, and nephrolithiasis (22) .
Studies in Clcn5
Y/Ϫ mice demonstrated that the loss of ClC-5 induces a defect in intracellular trafficking and membrane recycling in PT cells (20, 21, 25) , confirming the crucial role of vesicular chloride transporters along the endocytic pathway. Likewise, the moderate but significant alteration of LMW protein handling that was observed in Cftr Ϫ/Ϫ mice and patients with CF suggests that CFTR may play a role in PT endocytosis. In contrast to megalin, which is a member of the LDL recep- Urine samples were loaded on 5% PAGE, blotted to nitrocellulose, and incubated with antibody anti-cubilin (1:10,000). Loading volume was normalized to urine creatinine concentration. Cubilin abundance is increased significantly in the urine of Cftr Ϫ/Ϫ mice, whereas megalin is unchanged. Figure 7 . Low molecular weight proteinuria and calciuria in patients with CF or chronic lung inflammation. The urinary protein ratios for albumin, Clara cell protein (CC16), ␤ 2 -microglobulin (␤ 2 m), and transferrin, as well as the calciuria, were investigated in a first series of patients with CF and age-and gender-matched control subjects (n ϭ 30 pairs) and a second series of patients with active asthma (chronic lung inflammation) and their age-and gender-matched control subjects (n ϭ 25 pairs). The geometric mean (ϮSEM) normalized to the appropriate control (taken as 100%) is given for each parameter. *P Ͻ 0.05.
tor family, cubilin is a multiligand receptor with little structural homology to known endocytic receptors and is characterized by the absence of transmembrane domain (36) . Limited information is available about the regulators of cubilin targeting and processing in the PT. However, it was demonstrated recently that the apical targeting of cubilin depends on the correct glycosylation of its extracellular domains, as well as on reciprocal interactions with the transmembrane protein amnionless (37) . Our data support that CFTR is more abundant in the S3 segment of the PT and present in endosomes. Its functional loss is associated with a selective decrease of cubilin expression in the S3 segment ( Figure 5 ), reflected by the increased urinary excretion of cubilin ligands. Further investigations revealed that the lack of CFTR is not associated with changes in the biosynthesis of cubilin, as evidenced by similar mRNA levels (real-time PCR), similar glycosylation pattern (Figure 6 ), and similar bimodal distribution in subcellular fractions (data not shown). However, there was a significant increase in the urinary loss of cubilin in the Cftr Ϫ/Ϫ mice, contrasting with a lack of change for urinary megalin ( Figure 6 ). Taken together, these data suggest that the lack of CFTR in the S3 segment is reflected by an instability of cubilin in the apical membrane, leading to its accelerated shedding in the urine. Although the lack of suitable reagents prevented investigation of the specific role of amnionless in the process, it is tempting to hypothesize that such cubilin instability could be due to the improper processing or trafficking of one of its partners in relation with the lack of CFTR in that nephron segment (15, 17) . Of note, a decrease in cubilin has been observed in the small intestine of the CFTR null (Cftr tmlUNC ) mouse, which may explain a reduced vitamin B 12 absorption in patients with CF (38) . Moreover, preliminary data showing a lower renal uptake of aminoglycosides in CF mice in comparison with controls (F.J. et al., unpublished observations) suggest that the defect in receptor-mediated endocytosis reported here also may explain why the renal clearance of aminosides is enhanced in patients with CF (13, 39) .
The patients with CF examined here, all harboring at least one ⌬F508 mutation, showed a mild LMW proteinuria versus healthy control subjects, whereas no significant changes were observed in patients with chronic lung inflammation that was caused by active asthma. Of particular interest is the major, 30-fold increase in transferrinuria in the patients with CF, reflecting the cubilin defect and transferrinuria evidenced in the Cftr Ϫ/Ϫ mice. These findings may be clinically relevant, because LMW proteinuria can trigger tubulointerstitial injury (19, 36) . Moreover, the increased loss of transferrin in the urine could participate in the iron deficiency and lower circulating transferrin levels that are common in patients with CF (40, 41) . The endocytic defect was less consistent in the Cftr ⌬F/⌬F mice, which showed either unchanged or increased urinary excretion of LMW proteins. The mutant ⌬F508-CFTR shows defective glycosylation and traffic (2, 3) . However, ⌬F508-CFTR can function as a cAMP-regulated chloride channel, both in the plasma membrane and intracellularly (27) . Previous studies demonstrated a residual chloride permeability in intestine and gallbladder of the Cftr ⌬F/⌬F mice used here (24) , and the electrolyte and water handling is preserved in the PT of Cftr tm2cam ⌬F508
mice (42) . We documented an approximately two-fold reduction in ⌬F508-CFTR mRNA abundance in Cftr ⌬F/⌬F versus Cftr N/N kidneys (data not shown) and a large individual variability (ranging from 5 to 20% of the control level) in the residual expression of ⌬F508-CFTR protein. The expression of ⌬F508-CFTR in human is strikingly tissue specific, suggesting that the variable severity of CF in various organs reflects heterogeneity of residual expression (33, 43) . Taken together, these data suggest that, in mouse kidney, the ⌬F508-CFTR is processed variably into its mature form, reaching the plasma membrane and ensuring correct function in some Cftr ⌬F/⌬F mice.
Several explanations may account for the milder renal phenotype that is observed in Cftr Ϫ/Ϫ mice and patients with CF in comparison with Clcn5 KO mice and patients with Dent's disease (20 -22) . First, it could reflect the more distal distribution of CFTR as compared with ClC-5 along the PT. Indeed, although ClC-5 is distributed evenly in the S1 to S3 parts of the PT, CFTR seems to be most abundant in the S3 segment of the PT, which displays lower endocytic activity (44) . Second, CFTR functions as a cAMP-regulated, ATP-dependent chloride channel, whereas the flux of chloride through ClC-5 depends constitutively on transmembrane Cl Ϫ and H ϩ concentration gradient, together with the membrane voltage (18) . The number of active CFTR channels also is known to be regulated by cAMP-dependent vesicle trafficking, as well as by correct glycosylation (2, 35) . Third, the discrete nature of renal manifestations in CF might be due to tissue-specific protective mechanisms, such as the occurrence of functional CFTR splice variants (7, 8) , or alternative pathways for chloride (4) . 
Conclusion
The functional loss of CFTR is associated with a moderate but significant defect in LMW protein handling in mouse and human, supporting a role of CFTR in the cubilin-mediated endocytic pathway in renal PT cells. These data give new insights into the tissue-specific processing of wild-type and mutant CFTR and the pathophysiology of chloride transporters in the kidney. The urinary loss of LMW proteins, including transferrin, should be integrated in the pathophysiology of multisystemic complications that increasingly are observed in patients with CF.
